The Journal of Obstetrics and Gynecology of India

, Volume 67, Issue 6, pp 432–441 | Cite as

Serous Tubal Carcinogenesis: The Recent Concept of Origin of Ovarian, Primary Peritoneal and Fallopian Tube High-Grade Serous Carcinoma

  • Tushar Kar
  • Asaranti Kar
  • Ipsita Dhal
  • Sasmita Panda
  • Priyadarshini Biswal
  • Bhagyalaxmi Nayak
  • Niranjan Rout
  • Sagarika Samantray
Original Article



Pelvic (non-uterine) high-grade serous carcinomas (PHGSC) including ovarian, tubal and primary peritoneal serous carcinomas have increased death: incidence ratio due to presentation at advanced stage, rapid progression, poor prognosis and high morbidity. Ambiguity regarding their pathogenesis and lack of a proper screening method is the cause of their late detection and high fatality rate. This study was undertaken to assess the fallopian tube for the presence of precursor lesions in pelvic serous carcinoma.


This was a prospective case–control study carried out in a tertiary care center. Consecutive specimens of 55 cases of pelvic high-grade serous carcinoma and 41 controls inclusive of 21 low-grade serous carcinoma, 10 benign adnexal masses and 10 normal adnexa were included in the study. Both side fallopian tubes in each case were subjected to histopathological examination and p53, Ki67 immunohistochemistry.


There were 55 cases of PHGSC comprising of 50 cases of ovarian HGSC, two cases of primary peritoneal carcinoma (PPC) and three cases of tubal carcinoma. Serous tubal intraepithelial carcinoma (STIC) was detected in 14 cases (28%), p53 signature in 13 cases (26%) and tubal intraepithelial lesion in transition in 10 cases (20%) of ovarian HGSC. One case (50%) of PPC and one (33%) case of tubal carcinoma revealed the presence of STIC. None of the controls exhibited any precursor lesion except ovarian low-grade serous carcinoma where p53 was detected in 20% of cases.


This revelation concludes that fallopian tubes are the sites of precursors of PHGSC to a large extent. In the absence of a proper screening method of HGSC, prophylactic bilateral salpingectomy at hysterectomy for benign diseases can achieve ultimate goal of reduction in incidence of PHGSC.


Ovarian Tubal Primary peritoneal carcinoma Pelvic high-grade serous carcinoma Prophylactic salpingectomy Serous tubal intraepithelial carcinoma p53 Ki67 



We sincerely acknowledge the technical staff of S.C.B. Medical College, Cuttack, and AHRCC, Cuttack, for their effort and timely help.

Compliance with Ethical Standards

Conflict of interest

All the authors express that there is no conflict of interest.

Ethical committee approval was obtained from 2 centers

(1) Name of Institutional ethics committee (IEC)/Institutional review board (IRB)-Institutional ethics committee, S.C.B.Medical College, Cuttack, Orissa. Ethics Committee Regd. No. ERC/84/Inst/OR//2013 Issued under rule 122DD of the Drugs & Cosmetics Rules 1945. Ref.No-108 dated 22.11.2014. (2) Name of Institutional ethics committee (IEC)/Institutional review board (IRB)-Acharya Harihar Regional Cancer Centre Institutional ethics committee (AHRCC-IEC). Ethics Committee Regd. No. ERC/297/Inst/OR//2013 Issued under rule 122DD of the Drugs & Cosmetics Rules 1945. Ref.No-AHRCC-IEC/32 dated 25.11.2013.

Informed Consent

Informed consent—taken.

Human and Animal Consent

Animal studies should be clearly indicated—not done.


  1. 1.
    Crum CP. Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol. 2009;3:165–70.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Herrington CS, Mc Cluggage WG. The emerging role of the distal Fallopian tube and p53 in pelvic serous carcinogenesis. J Pathol. 2010;220:5–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Folkins AK, Jarboe EA, Roh MH, et al. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol. 2009;113:391–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31:161–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007;25:3985–90.CrossRefPubMedGoogle Scholar
  6. 6.
    Leeper K, Garcia R, Swisher E, et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol. 2002;87:52–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58–64.CrossRefPubMedGoogle Scholar
  8. 8.
    Powell CB, Kenley E, Chen LM, et al. Risk-reducing salpingooophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005;23:127–32.CrossRefPubMedGoogle Scholar
  9. 9.
    Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol. 2008;27:1–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Benedet JL, Ngan HYS, Hacker NF. For the FIGO committee on gynecologic oncology staging classifications and clinical practice guidelines of gynecologic cancers. Int J Gynecol Obstet. 2000;70:209–62.CrossRefGoogle Scholar
  11. 11.
    Lee KR, Tavassoli FA, Prat J, et al. Surface epithelial–stromal tumors. In: Tavassoli FA, Deville P, editors. World Health Organization classification of tumors pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003. p. 117–45.Google Scholar
  12. 12.
    Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Lee Y, Miron A, Drapkin R, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211:26–35.CrossRefPubMedGoogle Scholar
  14. 14.
    Crum CP, Drapkin R, Kindelberger D, et al. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5:35–44.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Vang R, Shih I, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology. 2013;62:44–58.CrossRefPubMedGoogle Scholar
  16. 16.
    Przybycin CG, Kurman RJ, Ronnett BM, et al. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol. 2010;34:1407–16.CrossRefPubMedGoogle Scholar
  17. 17.
    Tang S, Onuma K, Deb P, et al. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases. Int J Gynecol Pathol. 2012;31(2):103–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Mittal N, Srinivasan R, Gupta N, et al. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma. Indian J Pathol Microbiol. 2016;59:481–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Leonhardt K, Einenkel J, Sohr S, et al. p53 signature and serous tubal in situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol. 2011;30:417–24.CrossRefPubMedGoogle Scholar
  20. 20.
    Singer G, Sto R, Cope L, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis. Am J Surg Pathol. 2005;29:218–24.CrossRefPubMedGoogle Scholar
  21. 21.
    Gao F, Bhargava R, Yang H, et al. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: Is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Hum Pathol. 2013;44:1534–43.CrossRefPubMedGoogle Scholar
  22. 22.
    Seidman JD, Zhao P, Yemelyanova A. ”Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol. 2011;120:470–3.CrossRefPubMedGoogle Scholar
  23. 23.
    Reitsma W, de Bock GH, Oosterwijk JC, et al. Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens. Eur J Cancer. 2013;49:132–41.CrossRefPubMedGoogle Scholar
  24. 24.
    Jaime P, FIGO Committee on Gynecological Oncology. FIGO’s staging classification for cancer of ovary, fallopian tube and peritoneum: abridged republication. J Gynecol Oncol. 2015;26:87–9.CrossRefGoogle Scholar
  25. 25.
    McCluggage WG, Judge MJ, Clarke BA, et al. Data set for reporting of ovarian, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol. 2015;28:1101–22.CrossRefPubMedGoogle Scholar

Copyright information

© Federation of Obstetric & Gynecological Societies of India 2017

Authors and Affiliations

  • Tushar Kar
    • 1
  • Asaranti Kar
    • 2
  • Ipsita Dhal
    • 3
  • Sasmita Panda
    • 4
  • Priyadarshini Biswal
    • 5
  • Bhagyalaxmi Nayak
    • 6
  • Niranjan Rout
    • 4
  • Sagarika Samantray
    • 4
  1. 1.Department of Obstetrics & GynecologyVIMSARBurlaIndia
  2. 2.Department of PathologyS.C.B. Medical CollegeCuttackIndia
  3. 3.SR, Lady Hardinge Medical CollegeNew DelhiIndia
  4. 4.Department of OncopathologyAHRCCCuttackIndia
  5. 5.Department of PathologyS.C.B. Medical CollegeCuttackIndia
  6. 6.Department of Gynecologic OncologyAHRCCCuttackIndia

Personalised recommendations